Bulut Gökten, Dilara, and Rıdvan Mercan. 2026. “Clinical Outcomes After Switching from Originator Infliximab to the Biosimilar Ixifi in Patients With Axial Spondyloarthritis: A Single-Center Study from Türkiye”. Rheumatology (Bulgaria) 34 (1): 4-20. https://doi.org/10.35465/wx09tq86.